Advantis Corp. ADVT OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

32/100

0/3 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Advantis Corp. (ADVT) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 28/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

32/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

67/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

—

成长

N/A

No coverage

—

收入

N/A

No coverage

估值概览 — ADVT

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
1999	$0.00	$1.74M	$-2.71M	-156.4%
2015	$0.00	$36.82K	$108.59K	294.9%
2016	$0.00	$46.34K	$-106.09K	-228.9%
2017	$0.00	$406.21K	$-113.69K	-28%
2018	$0.00	$826.99K	$-23.64K	-2.9%
2019	$0.00	$0.00	$0.00	-
2020	$0.00	$0.00	$0.00	-
2021	$0.00	$0.00	$0.00	-
2022	$0.00	$0.00	$0.00	-